Fragile X Syndrome Phenotype Sample Clauses

Fragile X Syndrome Phenotype. Intellectual disability is the hallmark feature of fragile X syndrome. The level of impairment ranges from mild to severe, with IQ scores of affected males typically between 25 and 70. Arithmetic, spatial memory, abstract thought, and complex reasoning are particular areas of weakness (Xxxxxx et al. 1988), while verbal skills, including vocabulary and reading, are less significantly impaired (Xxxxxxxx et al. 1985). This is particularly true of receptive verbal skills, which are less impaired than expressive verbal skills (Xxxxxxx et al. 2001). Additionally, fragile X males tend to perform better at fact learning and school-related skills than at processing novel information (Xxxxxx et al. 1988). Furthermore, longitudinal studies suggest that the IQ of affected males declines over time, beyond their initial levels of impairment. The pattern of this decline is not consistent with a degenerative process, but rather a slowing of the intellectual growth of the fragile X male when compared to his unaffected peers and relatives (Xxxxxxx et al. 2005; Hall et al. 2008). There are three subtle physical findings which eluded Xxxxxx and Xxxx in their 1943 pedigree but are now known to be common in fragile X syndrome. The first of these is the typical facial appearance of fragile X patients. Although not grossly dysmorphic, certain common features are shared: a long, narrow face, prominent jaw, large forehead, and large everted ears (Xxxxxx et al. 1980). A subset of these facial features can be seen in over 90% of affected males, but less than half of affected females (Xxxxxxxx et al. 1994). Among the specific features, large ears are the most closely associated with fragile X as compared to other causes of intellectual disability (Xxxxxx et al. 2009). Macroorchidism, the second noteworthy physical feature, is present in nearly all postpubertal fragile X males (Xxxxxxxx et al. 1994; Xxxxxx et al. 2009). After multiple families were described with both X-linked ID and macroorchidism (Xxxxxx et al. 1975; Xxxxx et al. 1976; Xxxxxxxxx et al. 1977; Xxxxx et al. 1978), fragile X families were re- evaluated for the presence of enlarged testes, and macroorchidism was indeed found to be associated with fragile X syndrome (Xxxxxx et al. 1980). While a mouse model of fragile X showed increased Sertoli cell proliferation to be the cause of murine macroorchidism (Slegtenhorst-Eegdeman et al. 1998), no human studies have corroborated this finding; thus, the cause of macroorchidism i...
AutoNDA by SimpleDocs

Related to Fragile X Syndrome Phenotype

  • Rhytidectomy Scar revision, regardless of symptoms. • Sclerotherapy for spider veins. • Skin tag removal. • Subcutaneous injection of filling material. • Suction assisted Lipectomy. • Tattooing or tattoo removal except tattooing of the nipple/areola related to a mastectomy. • Treatment of vitiligo. • Standby services of an assistant surgeon or anesthesiologist. • Orthodontic services related to orthognathic surgery. • Cosmetic procedures when performed primarily: o to refine or reshape body structures or dental structures that are not functionally impaired; o to improve appearance or self-esteem; or o for other psychological, psychiatric or emotional reasons. • Drugs, biological products, hospital charges, pathology, radiology fees and charges for surgeons, assistant surgeons, attending physicians and any other incidental services, which are related to cosmetic surgery.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • Infection Control Consistent with the Centers for Disease Control and Prevention Guideline for Infection Control in Health Care Personnel, and University Policy 3364-109-EH-603, the parties agree that all bargaining unit employees who come in contact with patients in the hospital or ambulatory care clinics will need to be vaccinated against influenza when flu season begins each fall. The influenza vaccine will be offered to all health care workers, including pregnant women, before the influenza season, unless otherwise medically contraindicated or it compromises sincerely held religious beliefs.

  • Therapies Acupuncture and acupuncturist services, including x-ray and laboratory services. • Biofeedback, biofeedback training, and biofeedback by any other modality for any condition. • Recreational therapy services and programs, including wilderness programs. • Services provided in any covered program that are recreational therapy services, including wilderness programs, educational services, complimentary services, non- medical self-care, self-help programs, or non-clinical services. Examples include, but are not limited to, Tai Chi, yoga, personal training, meditation. • Computer/internet/social media based services and/or programs. • Recreational therapy. • Aqua therapy unless provided by a physical therapist. • Maintenance therapy services unless it is a habilitative service that helps a person keep, learn or improve skills and functioning for daily living. • Aromatherapy. • Hippotherapy. • Massage therapy rendered by a massage therapist. • Therapies, procedures, and services for the purpose of relieving stress. • Physical, occupational, speech, or respiratory therapy provided in your home, unless through a home care program. • Pelvic floor electrical and magnetic stimulation, and pelvic floor exercises. • Educational classes and services for speech impairments that are self-correcting. • Speech therapy services related to food aversion or texture disorders. • Exercise therapy. • Naturopathic, homeopathic, and Christian Science services, regardless of who orders or provides the services. Vision Care Services • Eye exercises and visual training services. • Lenses and/or frames and contact lenses for members aged nineteen (19) and older. • Vision hardware purchased from a non-network provider. • Non-collection vision hardware. • Lenses and/or frames and contact lenses unless specifically listed as a covered healthcare service.

  • Diagnosis For a condition to be considered a covered illness or disorder, copies of laboratory tests results, X-rays, or any other report or result of clinical examinations on which the diagnosis was based, are required as part of the positive diagnosis by a physician.

  • Speech Therapy This plan covers speech therapy services when provided by a qualified licensed provider and part of a formal treatment plan for: • loss of speech or communication function; or • impairment as a result of an acute illness or injury, or an acute exacerbation of a chronic disease. Speech therapy services must relate to: • performing basic functional communication; or • assessing or treating swallowing dysfunction. See Autism Services when speech therapy services are rendered as part of the treatment of autism spectrum disorder. The amount you pay and any benefit limit will be the same whether the services are provided for habilitative or rehabilitative purposes.

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

Time is Money Join Law Insider Premium to draft better contracts faster.